ArticleTrials2022

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.

Mieke van Schaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.